Free weekly newsletter
Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Serina Therapeutics Announces Strategic Partnership between Juvenescence Ltd. and M42 along with $76M Funding.
Jun 18, 2025•12 months ago
Contract Type
partnership
Description
Serina Therapeutics congratulates Juvenescence Ltd. on securing $76 million in the first tranche of its Series B financing and forming a strategic partnership with M42. This partnership aims to establish a drug development hub in Abu Dhabi to enhance drug discovery and therapeutic development targeting age-related diseases.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months